Reported 2 days ago
Amgen Inc. (NASDAQ:AMGN) is highlighted as one of the 'Dogs of the Dow,' recognized for its impressive dividend power and strong financial performance. With a revenue increase of 9.4% year-over-year, generating $8.15 billion, and robust free cash flow nearly doubling from the previous year, Amgen remains a reliable choice for dividend investors. The company's consistent dividend increases since 2011 and ongoing innovation in drug development further bolster its status as a standout pick among dividend stocks.
Source: YAHOO